Evaluation of tumor marker (PIVAK-II) in patients with positive HCV infection with and without cirrhosis complicated and uncomplicated with hepatocellular carcinoma - Egyptian Knowledge Bank - troweb

36646

Evaluation of tumor marker (PIVAK-II) in patients with positive HCV infection with and without cirrhosis complicated and uncomplicated with hepatocellular carcinoma

Thesis

Last updated: 06 Feb 2023

Overview Similar Items

Thesis

Diagnostic and prognostic value of PIVK-II, TGF-beta-1, VEGF and AFP in the diagnosis of benign and malignant liver diseases

Thesis

Diagnostic value of serum level of soluble tumor necrosis factor receptor II in patients with chronic hepatitis C virus infection and hepatocellular carcinoma

Thesis

Early detection of hepatocellular carcinoma in hepatitis "C" cirrhotic patients

Thesis

Study of serum level of interleukin 8 in patients with chronic liver disease due to hepatitis C with and without hepatocellular carcinoma

Thesis

Diagnostic Significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma

Thesis

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Thesis

Activity of serum angiotensin-converting enzyme as a tumor marker of hepatocellular carcinoma

Thesis

Significance of angiopoietin-2 as a serum marker for hepatocellular carcinoma

Thesis

Evaluation of vascular endothelial growth factor as a prognostic marker in hepatocellular carcinoma treated by locoregional therapy

Thesis

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C